nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminolevulinic acid—SLC15A1—Lisinopril—systemic scleroderma	0.432	0.572	CbGbCtD
Aminolevulinic acid—SLC15A1—Captopril—systemic scleroderma	0.323	0.428	CbGbCtD
Aminolevulinic acid—Skin disorder—Pentoxifylline—systemic scleroderma	0.000807	0.00329	CcSEcCtD
Aminolevulinic acid—Leukocytosis—Prednisone—systemic scleroderma	0.000789	0.00322	CcSEcCtD
Aminolevulinic acid—Ulcer—Prednisone—systemic scleroderma	0.000784	0.0032	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Azathioprine—systemic scleroderma	0.000777	0.00317	CcSEcCtD
Aminolevulinic acid—Hypotension—Pentoxifylline—systemic scleroderma	0.000776	0.00317	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Mycophenolic acid—systemic scleroderma	0.000776	0.00317	CcSEcCtD
Aminolevulinic acid—Infestation—Mycophenolic acid—systemic scleroderma	0.000776	0.00317	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Azathioprine—systemic scleroderma	0.000773	0.00316	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Leflunomide—systemic scleroderma	0.000769	0.00314	CcSEcCtD
Aminolevulinic acid—Tension—Captopril—systemic scleroderma	0.000757	0.00309	CcSEcCtD
Aminolevulinic acid—Petechiae—Methotrexate—systemic scleroderma	0.000754	0.00308	CcSEcCtD
Aminolevulinic acid—Nervousness—Captopril—systemic scleroderma	0.000749	0.00306	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Leflunomide—systemic scleroderma	0.000734	0.003	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Mycophenolic acid—systemic scleroderma	0.000734	0.003	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Leflunomide—systemic scleroderma	0.00073	0.00298	CcSEcCtD
Aminolevulinic acid—Aspartate aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.000715	0.00292	CcSEcCtD
Aminolevulinic acid—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.000715	0.00292	CcSEcCtD
Aminolevulinic acid—Anaemia—Captopril—systemic scleroderma	0.000713	0.00291	CcSEcCtD
Aminolevulinic acid—Infection—Mometasone—systemic scleroderma	0.000712	0.00291	CcSEcCtD
Aminolevulinic acid—Skin exfoliation—Prednisone—systemic scleroderma	0.000708	0.00289	CcSEcCtD
Aminolevulinic acid—Alanine aminotransferase increased—Mycophenolate mofetil—systemic scleroderma	0.000701	0.00286	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.0007	0.00286	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.000696	0.00284	CcSEcCtD
Aminolevulinic acid—Chills—Azathioprine—systemic scleroderma	0.000694	0.00283	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Mycophenolic acid—systemic scleroderma	0.000693	0.00283	CcSEcCtD
Aminolevulinic acid—Eye disorder—Leflunomide—systemic scleroderma	0.000682	0.00279	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Leflunomide—systemic scleroderma	0.000677	0.00277	CcSEcCtD
Aminolevulinic acid—Herpes simplex—Methotrexate—systemic scleroderma	0.000673	0.00275	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.000661	0.0027	CcSEcCtD
Aminolevulinic acid—Urticaria—Pentoxifylline—systemic scleroderma	0.00066	0.00269	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000656	0.00268	CcSEcCtD
Aminolevulinic acid—Ulcer—Methotrexate—systemic scleroderma	0.000655	0.00268	CcSEcCtD
Aminolevulinic acid—Chills—Leflunomide—systemic scleroderma	0.000655	0.00267	CcSEcCtD
Aminolevulinic acid—Eye disorder—Mycophenolic acid—systemic scleroderma	0.000651	0.00266	CcSEcCtD
Aminolevulinic acid—Discomfort—Captopril—systemic scleroderma	0.000649	0.00265	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.000646	0.00264	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Mometasone—systemic scleroderma	0.000643	0.00263	CcSEcCtD
Aminolevulinic acid—Mental disorder—Leflunomide—systemic scleroderma	0.00064	0.00261	CcSEcCtD
Aminolevulinic acid—Angiopathy—Mycophenolic acid—systemic scleroderma	0.000632	0.00258	CcSEcCtD
Aminolevulinic acid—Respiratory failure—Methotrexate—systemic scleroderma	0.000631	0.00258	CcSEcCtD
Aminolevulinic acid—Chills—Mycophenolic acid—systemic scleroderma	0.000625	0.00255	CcSEcCtD
Aminolevulinic acid—Anaemia—Azathioprine—systemic scleroderma	0.000622	0.00254	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Captopril—systemic scleroderma	0.000616	0.00252	CcSEcCtD
Aminolevulinic acid—Pain—Mometasone—systemic scleroderma	0.000613	0.0025	CcSEcCtD
Aminolevulinic acid—Infestation—Mycophenolate mofetil—systemic scleroderma	0.000612	0.0025	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Mycophenolate mofetil—systemic scleroderma	0.000612	0.0025	CcSEcCtD
Aminolevulinic acid—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00061	0.00249	CcSEcCtD
Aminolevulinic acid—Tension—Mycophenolic acid—systemic scleroderma	0.000595	0.00243	CcSEcCtD
Aminolevulinic acid—Skin exfoliation—Methotrexate—systemic scleroderma	0.000592	0.00242	CcSEcCtD
Aminolevulinic acid—Nervousness—Mycophenolic acid—systemic scleroderma	0.000589	0.0024	CcSEcCtD
Aminolevulinic acid—Hypotension—Captopril—systemic scleroderma	0.000588	0.0024	CcSEcCtD
Aminolevulinic acid—Pruritus—Pentoxifylline—systemic scleroderma	0.000587	0.0024	CcSEcCtD
Aminolevulinic acid—Anaemia—Leflunomide—systemic scleroderma	0.000587	0.0024	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.000579	0.00236	CcSEcCtD
Aminolevulinic acid—Angiopathy—Lisinopril—systemic scleroderma	0.000569	0.00232	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000569	0.00232	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000568	0.00232	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Mometasone—systemic scleroderma	0.000566	0.00231	CcSEcCtD
Aminolevulinic acid—Discomfort—Azathioprine—systemic scleroderma	0.000566	0.00231	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Captopril—systemic scleroderma	0.000565	0.00231	CcSEcCtD
Aminolevulinic acid—Chills—Lisinopril—systemic scleroderma	0.000563	0.0023	CcSEcCtD
Aminolevulinic acid—Neoplasm—Methotrexate—systemic scleroderma	0.000561	0.00229	CcSEcCtD
Aminolevulinic acid—Anaemia—Mycophenolic acid—systemic scleroderma	0.00056	0.00229	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000552	0.00226	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00055	0.00224	CcSEcCtD
Aminolevulinic acid—Mental disorder—Lisinopril—systemic scleroderma	0.00055	0.00224	CcSEcCtD
Aminolevulinic acid—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.000547	0.00223	CcSEcCtD
Aminolevulinic acid—Erythema—Lisinopril—systemic scleroderma	0.000546	0.00223	CcSEcCtD
Aminolevulinic acid—Infection—Azathioprine—systemic scleroderma	0.000546	0.00223	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000538	0.0022	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000537	0.00219	CcSEcCtD
Aminolevulinic acid—Tension—Lisinopril—systemic scleroderma	0.000536	0.00219	CcSEcCtD
Aminolevulinic acid—Discomfort—Leflunomide—systemic scleroderma	0.000535	0.00218	CcSEcCtD
Aminolevulinic acid—Skin disorder—Azathioprine—systemic scleroderma	0.000533	0.00218	CcSEcCtD
Aminolevulinic acid—Nervousness—Lisinopril—systemic scleroderma	0.00053	0.00217	CcSEcCtD
Aminolevulinic acid—Vomiting—Pentoxifylline—systemic scleroderma	0.000528	0.00216	CcSEcCtD
Aminolevulinic acid—Convulsion—Mycophenolic acid—systemic scleroderma	0.000525	0.00215	CcSEcCtD
Aminolevulinic acid—Rash—Pentoxifylline—systemic scleroderma	0.000524	0.00214	CcSEcCtD
Aminolevulinic acid—Dermatitis—Pentoxifylline—systemic scleroderma	0.000523	0.00214	CcSEcCtD
Aminolevulinic acid—Headache—Pentoxifylline—systemic scleroderma	0.00052	0.00212	CcSEcCtD
Aminolevulinic acid—Infection—Leflunomide—systemic scleroderma	0.000515	0.0021	CcSEcCtD
Aminolevulinic acid—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000514	0.0021	CcSEcCtD
Aminolevulinic acid—Hypotension—Azathioprine—systemic scleroderma	0.000513	0.0021	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000513	0.00209	CcSEcCtD
Aminolevulinic acid—Photosensitivity—Methotrexate—systemic scleroderma	0.000513	0.00209	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00051	0.00208	CcSEcCtD
Aminolevulinic acid—Discomfort—Mycophenolic acid—systemic scleroderma	0.00051	0.00208	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Leflunomide—systemic scleroderma	0.000509	0.00208	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000508	0.00207	CcSEcCtD
Aminolevulinic acid—Pruritus—Mometasone—systemic scleroderma	0.000507	0.00207	CcSEcCtD
Aminolevulinic acid—Anaemia—Lisinopril—systemic scleroderma	0.000505	0.00206	CcSEcCtD
Aminolevulinic acid—Skin disorder—Leflunomide—systemic scleroderma	0.000504	0.00206	CcSEcCtD
Aminolevulinic acid—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000499	0.00204	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Captopril—systemic scleroderma	0.000497	0.00203	CcSEcCtD
Aminolevulinic acid—Oedema—Mycophenolic acid—systemic scleroderma	0.000495	0.00202	CcSEcCtD
Aminolevulinic acid—Dry skin—Prednisone—systemic scleroderma	0.000494	0.00202	CcSEcCtD
Aminolevulinic acid—Nausea—Pentoxifylline—systemic scleroderma	0.000493	0.00201	CcSEcCtD
Aminolevulinic acid—Chills—Mycophenolate mofetil—systemic scleroderma	0.000493	0.00201	CcSEcCtD
Aminolevulinic acid—Infection—Mycophenolic acid—systemic scleroderma	0.000492	0.00201	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Mometasone—systemic scleroderma	0.00049	0.002	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000485	0.00198	CcSEcCtD
Aminolevulinic acid—Hypotension—Leflunomide—systemic scleroderma	0.000485	0.00198	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000484	0.00198	CcSEcCtD
Aminolevulinic acid—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000481	0.00197	CcSEcCtD
Aminolevulinic acid—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000481	0.00196	CcSEcCtD
Aminolevulinic acid—Alanine aminotransferase increased—Prednisone—systemic scleroderma	0.000475	0.00194	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000474	0.00194	CcSEcCtD
Aminolevulinic acid—Tension—Mycophenolate mofetil—systemic scleroderma	0.000469	0.00192	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Leflunomide—systemic scleroderma	0.000466	0.0019	CcSEcCtD
Aminolevulinic acid—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000465	0.0019	CcSEcCtD
Aminolevulinic acid—Hypotension—Mycophenolic acid—systemic scleroderma	0.000462	0.00189	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000462	0.00189	CcSEcCtD
Aminolevulinic acid—Discomfort—Lisinopril—systemic scleroderma	0.000459	0.00188	CcSEcCtD
Aminolevulinic acid—Vomiting—Mometasone—systemic scleroderma	0.000456	0.00186	CcSEcCtD
Aminolevulinic acid—Rash—Mometasone—systemic scleroderma	0.000452	0.00184	CcSEcCtD
Aminolevulinic acid—Dermatitis—Mometasone—systemic scleroderma	0.000451	0.00184	CcSEcCtD
Aminolevulinic acid—Headache—Mometasone—systemic scleroderma	0.000449	0.00183	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000448	0.00183	CcSEcCtD
Aminolevulinic acid—Oedema—Lisinopril—systemic scleroderma	0.000446	0.00182	CcSEcCtD
Aminolevulinic acid—Pruritus—Captopril—systemic scleroderma	0.000445	0.00182	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000444	0.00181	CcSEcCtD
Aminolevulinic acid—Pain—Leflunomide—systemic scleroderma	0.000443	0.00181	CcSEcCtD
Aminolevulinic acid—Infection—Lisinopril—systemic scleroderma	0.000443	0.00181	CcSEcCtD
Aminolevulinic acid—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000442	0.00181	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000436	0.00178	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Azathioprine—systemic scleroderma	0.000434	0.00177	CcSEcCtD
Aminolevulinic acid—Skin disorder—Lisinopril—systemic scleroderma	0.000433	0.00177	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Captopril—systemic scleroderma	0.000431	0.00176	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000427	0.00174	CcSEcCtD
Aminolevulinic acid—Nausea—Mometasone—systemic scleroderma	0.000426	0.00174	CcSEcCtD
Aminolevulinic acid—Pain—Mycophenolic acid—systemic scleroderma	0.000423	0.00173	CcSEcCtD
Aminolevulinic acid—Hypotension—Lisinopril—systemic scleroderma	0.000416	0.0017	CcSEcCtD
Aminolevulinic acid—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000415	0.00169	CcSEcCtD
Aminolevulinic acid—Urticaria—Leflunomide—systemic scleroderma	0.000412	0.00168	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Leflunomide—systemic scleroderma	0.00041	0.00167	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000404	0.00165	CcSEcCtD
Aminolevulinic acid—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000402	0.00164	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Lisinopril—systemic scleroderma	0.0004	0.00163	CcSEcCtD
Aminolevulinic acid—Vomiting—Captopril—systemic scleroderma	0.0004	0.00163	CcSEcCtD
Aminolevulinic acid—Rash—Captopril—systemic scleroderma	0.000397	0.00162	CcSEcCtD
Aminolevulinic acid—Dermatitis—Captopril—systemic scleroderma	0.000396	0.00162	CcSEcCtD
Aminolevulinic acid—Headache—Captopril—systemic scleroderma	0.000394	0.00161	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000391	0.0016	CcSEcCtD
Aminolevulinic acid—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00039	0.00159	CcSEcCtD
Aminolevulinic acid—Infection—Mycophenolate mofetil—systemic scleroderma	0.000388	0.00158	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000385	0.00157	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00156	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000382	0.00156	CcSEcCtD
Aminolevulinic acid—Pain—Lisinopril—systemic scleroderma	0.000381	0.00156	CcSEcCtD
Aminolevulinic acid—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000379	0.00155	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Azathioprine—systemic scleroderma	0.000376	0.00153	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Prednisone—systemic scleroderma	0.000374	0.00153	CcSEcCtD
Aminolevulinic acid—Nausea—Captopril—systemic scleroderma	0.000374	0.00153	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Prednisone—systemic scleroderma	0.000373	0.00152	CcSEcCtD
Aminolevulinic acid—Pruritus—Leflunomide—systemic scleroderma	0.000367	0.0015	CcSEcCtD
Aminolevulinic acid—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000365	0.00149	CcSEcCtD
Aminolevulinic acid—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000355	0.00145	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Leflunomide—systemic scleroderma	0.000355	0.00145	CcSEcCtD
Aminolevulinic acid—Urticaria—Lisinopril—systemic scleroderma	0.000354	0.00145	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Lisinopril—systemic scleroderma	0.000352	0.00144	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000351	0.00143	CcSEcCtD
Aminolevulinic acid—Pruritus—Mycophenolic acid—systemic scleroderma	0.00035	0.00143	CcSEcCtD
Aminolevulinic acid—Vomiting—Azathioprine—systemic scleroderma	0.000349	0.00143	CcSEcCtD
Aminolevulinic acid—Eye disorder—Prednisone—systemic scleroderma	0.000348	0.00142	CcSEcCtD
Aminolevulinic acid—Infestation NOS—Methotrexate—systemic scleroderma	0.000347	0.00142	CcSEcCtD
Aminolevulinic acid—Infestation—Methotrexate—systemic scleroderma	0.000347	0.00142	CcSEcCtD
Aminolevulinic acid—Rash—Azathioprine—systemic scleroderma	0.000346	0.00141	CcSEcCtD
Aminolevulinic acid—Dermatitis—Azathioprine—systemic scleroderma	0.000346	0.00141	CcSEcCtD
Aminolevulinic acid—Headache—Azathioprine—systemic scleroderma	0.000344	0.00141	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000339	0.00138	CcSEcCtD
Aminolevulinic acid—Angiopathy—Prednisone—systemic scleroderma	0.000338	0.00138	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000337	0.00138	CcSEcCtD
Aminolevulinic acid—Pain—Mycophenolate mofetil—systemic scleroderma	0.000334	0.00136	CcSEcCtD
Aminolevulinic acid—Vomiting—Leflunomide—systemic scleroderma	0.00033	0.00135	CcSEcCtD
Aminolevulinic acid—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000328	0.00134	CcSEcCtD
Aminolevulinic acid—Rash—Leflunomide—systemic scleroderma	0.000327	0.00134	CcSEcCtD
Aminolevulinic acid—Dermatitis—Leflunomide—systemic scleroderma	0.000327	0.00133	CcSEcCtD
Aminolevulinic acid—Mental disorder—Prednisone—systemic scleroderma	0.000326	0.00133	CcSEcCtD
Aminolevulinic acid—Nausea—Azathioprine—systemic scleroderma	0.000326	0.00133	CcSEcCtD
Aminolevulinic acid—Headache—Leflunomide—systemic scleroderma	0.000325	0.00133	CcSEcCtD
Aminolevulinic acid—Erythema—Prednisone—systemic scleroderma	0.000324	0.00132	CcSEcCtD
Aminolevulinic acid—Pruritus—Lisinopril—systemic scleroderma	0.000315	0.00129	CcSEcCtD
Aminolevulinic acid—Vomiting—Mycophenolic acid—systemic scleroderma	0.000315	0.00128	CcSEcCtD
Aminolevulinic acid—Haemoglobin—Methotrexate—systemic scleroderma	0.000313	0.00128	CcSEcCtD
Aminolevulinic acid—Rash—Mycophenolic acid—systemic scleroderma	0.000312	0.00127	CcSEcCtD
Aminolevulinic acid—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000312	0.00127	CcSEcCtD
Aminolevulinic acid—Haemorrhage—Methotrexate—systemic scleroderma	0.000311	0.00127	CcSEcCtD
Aminolevulinic acid—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00031	0.00127	CcSEcCtD
Aminolevulinic acid—Headache—Mycophenolic acid—systemic scleroderma	0.00031	0.00127	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000309	0.00126	CcSEcCtD
Aminolevulinic acid—Nausea—Leflunomide—systemic scleroderma	0.000308	0.00126	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Lisinopril—systemic scleroderma	0.000305	0.00125	CcSEcCtD
Aminolevulinic acid—Anaemia—Prednisone—systemic scleroderma	0.0003	0.00122	CcSEcCtD
Aminolevulinic acid—Nausea—Mycophenolic acid—systemic scleroderma	0.000294	0.0012	CcSEcCtD
Aminolevulinic acid—Eye disorder—Methotrexate—systemic scleroderma	0.000291	0.00119	CcSEcCtD
Aminolevulinic acid—Cardiac disorder—Methotrexate—systemic scleroderma	0.000289	0.00118	CcSEcCtD
Aminolevulinic acid—Vomiting—Lisinopril—systemic scleroderma	0.000283	0.00116	CcSEcCtD
Aminolevulinic acid—Angiopathy—Methotrexate—systemic scleroderma	0.000282	0.00115	CcSEcCtD
Aminolevulinic acid—Rash—Lisinopril—systemic scleroderma	0.000281	0.00115	CcSEcCtD
Aminolevulinic acid—Convulsion—Prednisone—systemic scleroderma	0.000281	0.00115	CcSEcCtD
Aminolevulinic acid—Dermatitis—Lisinopril—systemic scleroderma	0.000281	0.00115	CcSEcCtD
Aminolevulinic acid—Chills—Methotrexate—systemic scleroderma	0.000279	0.00114	CcSEcCtD
Aminolevulinic acid—Headache—Lisinopril—systemic scleroderma	0.000279	0.00114	CcSEcCtD
Aminolevulinic acid—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000276	0.00113	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000274	0.00112	CcSEcCtD
Aminolevulinic acid—Discomfort—Prednisone—systemic scleroderma	0.000273	0.00111	CcSEcCtD
Aminolevulinic acid—Mental disorder—Methotrexate—systemic scleroderma	0.000273	0.00111	CcSEcCtD
Aminolevulinic acid—Erythema—Methotrexate—systemic scleroderma	0.000271	0.00111	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00109	CcSEcCtD
Aminolevulinic acid—Nausea—Lisinopril—systemic scleroderma	0.000265	0.00108	CcSEcCtD
Aminolevulinic acid—Oedema—Prednisone—systemic scleroderma	0.000265	0.00108	CcSEcCtD
Aminolevulinic acid—Infection—Prednisone—systemic scleroderma	0.000263	0.00107	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Prednisone—systemic scleroderma	0.00026	0.00106	CcSEcCtD
Aminolevulinic acid—Skin disorder—Prednisone—systemic scleroderma	0.000257	0.00105	CcSEcCtD
Aminolevulinic acid—Anaemia—Methotrexate—systemic scleroderma	0.00025	0.00102	CcSEcCtD
Aminolevulinic acid—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000248	0.00101	CcSEcCtD
Aminolevulinic acid—Rash—Mycophenolate mofetil—systemic scleroderma	0.000246	0.00101	CcSEcCtD
Aminolevulinic acid—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000246	0.001	CcSEcCtD
Aminolevulinic acid—Headache—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000999	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Prednisone—systemic scleroderma	0.000238	0.000971	CcSEcCtD
Aminolevulinic acid—Convulsion—Methotrexate—systemic scleroderma	0.000235	0.000959	CcSEcCtD
Aminolevulinic acid—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000947	CcSEcCtD
Aminolevulinic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000229	0.000936	CcSEcCtD
Aminolevulinic acid—Discomfort—Methotrexate—systemic scleroderma	0.000228	0.000931	CcSEcCtD
Aminolevulinic acid—Infection—Methotrexate—systemic scleroderma	0.00022	0.000897	CcSEcCtD
Aminolevulinic acid—Nervous system disorder—Methotrexate—systemic scleroderma	0.000217	0.000886	CcSEcCtD
Aminolevulinic acid—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000217	0.000884	CcSEcCtD
Aminolevulinic acid—Skin disorder—Methotrexate—systemic scleroderma	0.000215	0.000877	CcSEcCtD
Aminolevulinic acid—Urticaria—Prednisone—systemic scleroderma	0.00021	0.000859	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Prednisone—systemic scleroderma	0.000209	0.000854	CcSEcCtD
Aminolevulinic acid—Hypotension—Methotrexate—systemic scleroderma	0.000207	0.000844	CcSEcCtD
Aminolevulinic acid—Paraesthesia—Methotrexate—systemic scleroderma	0.000199	0.000811	CcSEcCtD
Aminolevulinic acid—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000191	0.00078	CcSEcCtD
Aminolevulinic acid—Pain—Methotrexate—systemic scleroderma	0.000189	0.000772	CcSEcCtD
Aminolevulinic acid—Pruritus—Prednisone—systemic scleroderma	0.000187	0.000765	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Prednisone—systemic scleroderma	0.000181	0.00074	CcSEcCtD
Aminolevulinic acid—Urticaria—Methotrexate—systemic scleroderma	0.000176	0.000718	CcSEcCtD
Aminolevulinic acid—Body temperature increased—Methotrexate—systemic scleroderma	0.000175	0.000714	CcSEcCtD
Aminolevulinic acid—Vomiting—Prednisone—systemic scleroderma	0.000168	0.000687	CcSEcCtD
Aminolevulinic acid—Rash—Prednisone—systemic scleroderma	0.000167	0.000682	CcSEcCtD
Aminolevulinic acid—Dermatitis—Prednisone—systemic scleroderma	0.000167	0.000681	CcSEcCtD
Aminolevulinic acid—Headache—Prednisone—systemic scleroderma	0.000166	0.000677	CcSEcCtD
Aminolevulinic acid—Nausea—Prednisone—systemic scleroderma	0.000157	0.000642	CcSEcCtD
Aminolevulinic acid—Pruritus—Methotrexate—systemic scleroderma	0.000156	0.000639	CcSEcCtD
Aminolevulinic acid—Diarrhoea—Methotrexate—systemic scleroderma	0.000151	0.000618	CcSEcCtD
Aminolevulinic acid—Vomiting—Methotrexate—systemic scleroderma	0.000141	0.000574	CcSEcCtD
Aminolevulinic acid—Rash—Methotrexate—systemic scleroderma	0.000139	0.00057	CcSEcCtD
Aminolevulinic acid—Dermatitis—Methotrexate—systemic scleroderma	0.000139	0.000569	CcSEcCtD
Aminolevulinic acid—Headache—Methotrexate—systemic scleroderma	0.000139	0.000566	CcSEcCtD
Aminolevulinic acid—Nausea—Methotrexate—systemic scleroderma	0.000131	0.000537	CcSEcCtD
Aminolevulinic acid—ALAD—connective tissue—systemic scleroderma	0.000104	0.286	CbGeAlD
Aminolevulinic acid—ALAD—digestive system—systemic scleroderma	7.53e-05	0.207	CbGeAlD
Aminolevulinic acid—ALAD—tendon—systemic scleroderma	7.17e-05	0.197	CbGeAlD
Aminolevulinic acid—ALAD—lung—systemic scleroderma	6.29e-05	0.173	CbGeAlD
Aminolevulinic acid—SLC15A1—digestive system—systemic scleroderma	3.31e-05	0.0907	CbGeAlD
Aminolevulinic acid—SLC15A2—lung—systemic scleroderma	1.73e-05	0.0474	CbGeAlD
